Effect of Carvedilol on Exercise Performance in Fontan Patients
Status:
Completed
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
This study evaluates the effect of carvedilol in patients who have undergone a Fontan heart
operation. All participants will receive carvedilol and placebo for 12 weeks. Exercise tests
will be performed at the end of each 12 week period.